GSK3B and type 2 diabetes mellitus: Moreover, network pharmacology study involve common targets of bergaptol and type 2 diabetes, which was further applied for gene ontology suggested INSR, NF-κB, Akt and GSK-3β targets for the insulin signalling and resistance both.